| Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ... Nature Medicine, 1-9, 2021 | 499 | 2021 |
| Early alterations of the innate and adaptive immune statuses in sepsis according to the type of underlying infection C Gogos, A Kotsaki, A Pelekanou, G Giannikopoulos, I Vaki, P Maravitsa, ... Critical Care 14, 1-12, 2010 | 173 | 2010 |
| An open label trial of anakinra to prevent respiratory failure in COVID-19 E Kyriazopoulou, P Panagopoulos, S Metallidis, GN Dalekos, G Poulakou, ... Elife 10, e66125, 2021 | 166 | 2021 |
| Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis E Kyriazopoulou, T Huet, G Cavalli, A Gori, M Kyprianou, P Pickkers, ... The Lancet Rheumatology 3 (10), e690-e697, 2021 | 152 | 2021 |
| ACTIVATE-2: a double-blind randomized trial of BCG vaccination against COVID-19 in individuals at risk M Tsilika, E Taks, K Dolianitis, A Kotsaki, K Leventogiannis, C Damoulari, ... Frontiers in immunology 13, 873067, 2022 | 100 | 2022 |
| diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study walsh simon european respiratory journal 50 (2), 2017 | 99 | 2017 |
| Patterns of airway involvement in inflammatory bowel diseases I Papanikolaou, K Kagouridis, SA Papiris World journal of gastrointestinal pathophysiology 5 (4), 560, 2014 | 86 | 2014 |
| Cardiac sarcoidosis: diagnosis and management E Markatis, A Afthinos, E Antonakis, IC Papanikolaou Reviews in Cardiovascular Medicine 21 (3), 321-338, 2020 | 68 | 2020 |
| Increased monocyte count and red cell distribution width as prognostic biomarkers in patients with Idiopathic Pulmonary Fibrosis T Karampitsakos, S Torrisi, K Antoniou, E Manali, I Korbila, ... Respiratory research 22 (1), 140, 2021 | 52 | 2021 |
| The relationship between sarcoidosis and lymphoma IC Papanikolaou, OP Sharma European Respiratory Journal 36 (5), 1207-1219, 2010 | 52 | 2010 |
| Lung cancer in patients with idiopathic pulmonary fibrosis: A retrospective multicentre study in Europe Respirology, 2022 | 42* | 2022 |
| Lung cancer in patients with idiopathic pulmonary fibrosis. A retrospective multicenter study in Greece A Tzouvelekis, T Karampitsakos, G Gomatou, E Bouros, V Tzilas, E Manali, ... Pulmonary pharmacology & therapeutics 60, 101880, 2020 | 41 | 2020 |
| Current concepts regarding calcium metabolism and bone health in sarcoidosis RP Baughman, I Papanikolaou Current Opinion in Pulmonary Medicine 23 (5), 476-481, 2017 | 34 | 2017 |
| Acute exacerbations of interstitial lung diseases IC Papanikolaou, F Drakopanagiotakis, VS Polychronopoulos Current opinion in pulmonary medicine 16 (5), 480-486, 2010 | 31 | 2010 |
| Reduction in hospitalizations for respiratory diseases during the first COVID-19 wave in Greece C Kyriakopoulos, A Gogali, K Exarchos, D Potonos, K Tatsis, ... Respiration 100 (7), 588-593, 2021 | 30 | 2021 |
| Development and validation of SCOPE score: A clinical score to predict COVID-19 pneumonia progression to severe respiratory failure EJ Giamarellos-Bourboulis, G Poulakou, A de Nooijer, H Milionis, ... Cell Reports Medicine 3 (3), 2022 | 29 | 2022 |
| Serum levels of surfactant proteins in patients with combined pulmonary fibrosis and emphysema (CPFE) AI Papaioannou, K Kostikas, ED Manali, G Papadaki, A Roussou, ... PloS one 11 (6), e0157789, 2016 | 22 | 2016 |
| Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases IC Papanikolaou, KA Boki, EJ Giamarellos-Bourboulis, A Kotsaki, ... Immunology letters 163 (2), 179-186, 2015 | 21 | 2015 |
| RELIght: A two-year REal-LIfe study of mepolizumab in patients with severe eosinophilic asTHma in Greece: Evaluating the multiple components of response K M, Z E, F E, P K, M MH, T E, M M, N M, P AI, L P, D K, K S, A S, P A, K K, ... Allergy 2022, PMID: 35595723, 2022 | 19* | 2022 |
| Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial EJ Giamarellos-Bourboulis, A Siampanos, A Bolanou, S Doulou, ... The Lancet Respiratory Medicine 12 (4), 294-304, 2024 | 16 | 2024 |
